FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141711493> ?p ?o ?g. }

• W2141711493 endingPage "694" @default.
• W2141711493 startingPage "687" @default.
• W2141711493 abstract "The aim of this study was to provide a comparative description of geographical variations and time trends in the population-based survival of European children with acute lymphoblastic leukaemia (ALL). Data on 13344 newly diagnosed children (0--14 years) with ALL were included in the EUROCARE study and were collected were collected by 34 population-based cancer registries (four comprising only childhood malignancies), operating in 17 countries (four in Scandinavia, two in Southern Europe, three in Eastern Europe, six in Continental Europe and two in the UK). Age-specific crude survival rates were estimated for boys and girls according to country for the period 1985--1989 and in adjusted form to attain comparability. Overall pooled and weighted rates were estimated as European standards. Children dead at diagnosis or diagnosed only through a death certificate were excluded. Geographical variation was also estimated by calculating the relative death rate with respect to the pooled overall European rate. After adjustment for age, gender and country, a Cox regression analysis was used to estimate time trends in survival. Survival was compared with that in the USA, Japan, Canada and Australia. During 1985--1989, the 1-year survival rate varied from 99 to 79%, the 5-year survival rate from over 80 to 56% (with the exception of Estonia; 34%; 95% confidence interval (CI) 20--52) among the various countries; the European weighted means were 90 (95% CI 87--93) and 72% (95% CI 69--75), respectively. Survival was particularly favourable in (south) Sweden, Finland, Germany and The Netherlands and rather unfavourable in Estonia and (surprisingly) France, where only 4% of its population was covered by the participating registries. Compared with the period 1978--1981, the hazard ratio for the period 1986--1989 decreased to 0.59 (95% CI 0.54--0.64) and -- in a smaller set of registries -- to 0.49 (0.45--0.55) for 1990-1992, an annual decrease in this rate of approximately 3.5%. During 1985--1989, the 5-year survival rates for European children were largely similar to those found in the USA, Canada and Australia, but markedly better than those in Japan. Higher survival rates were found for countries with 'good' access to centrally organised diagnostic and treatment facilities which stimulated 'aggressive' treatments according to a protocol. However, a subdivision according to risk profiles, e.g. according to the initial white blood cell count at diagnosis, could not be made and this might have explained partially the geographical differences in survival, because a positive association appeared between incidence at age 1--4 years and 5-year survival in most countries." @default.
• W2141711493 created "2016-06-24" @default.
• W2141711493 creator A5003169705 @default.
• W2141711493 creator A5025847738 @default.
• W2141711493 creator A5033644402 @default.
• W2141711493 creator A5052499796 @default.
• W2141711493 creator A5063051528 @default.
• W2141711493 date "2001-04-01" @default.
• W2141711493 modified "2023-09-23" @default.
• W2141711493 title "Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978–1992" @default.
• W2141711493 cites W1580788756 @default.
• W2141711493 cites W1948070639 @default.
• W2141711493 cites W1973220007 @default.
• W2141711493 cites W2005671942 @default.
• W2141711493 cites W2006691249 @default.
• W2141711493 cites W2011736502 @default.
• W2141711493 cites W2017342544 @default.
• W2141711493 cites W2018967061 @default.
• W2141711493 cites W2037723640 @default.
• W2141711493 cites W2053388534 @default.
• W2141711493 cites W2054036109 @default.
• W2141711493 cites W2054224447 @default.
• W2141711493 cites W2068494677 @default.
• W2141711493 cites W2070173503 @default.
• W2141711493 cites W207998098 @default.
• W2141711493 cites W2086283014 @default.
• W2141711493 cites W2109995740 @default.
• W2141711493 cites W2119685895 @default.
• W2141711493 cites W2145641630 @default.
• W2141711493 cites W2145705295 @default.
• W2141711493 cites W2147996630 @default.
• W2141711493 cites W2148244471 @default.
• W2141711493 cites W2154212069 @default.
• W2141711493 cites W2191505845 @default.
• W2141711493 cites W2223173982 @default.
• W2141711493 cites W2394739561 @default.
• W2141711493 cites W2409457249 @default.
• W2141711493 cites W2516136647 @default.
• W2141711493 cites W63968789 @default.
• W2141711493 cites W804164856 @default.
• W2141711493 doi "https://doi.org/10.1016/s0959-8049(01)00013-2" @default.
• W2141711493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11311642" @default.
• W2141711493 hasPublicationYear "2001" @default.
• W2141711493 type Work @default.
• W2141711493 sameAs 2141711493 @default.
• W2141711493 citedByCount "34" @default.
• W2141711493 countsByYear W21417114932012 @default.
• W2141711493 countsByYear W21417114932013 @default.
• W2141711493 countsByYear W21417114932016 @default.
• W2141711493 countsByYear W21417114932017 @default.
• W2141711493 crossrefType "journal-article" @default.
• W2141711493 hasAuthorship W2141711493A5003169705 @default.
• W2141711493 hasAuthorship W2141711493A5025847738 @default.
• W2141711493 hasAuthorship W2141711493A5033644402 @default.
• W2141711493 hasAuthorship W2141711493A5052499796 @default.
• W2141711493 hasAuthorship W2141711493A5063051528 @default.
• W2141711493 hasConcept C114614502 @default.
• W2141711493 hasConcept C126322002 @default.
• W2141711493 hasConcept C144024400 @default.
• W2141711493 hasConcept C149923435 @default.
• W2141711493 hasConcept C187212893 @default.
• W2141711493 hasConcept C197947376 @default.
• W2141711493 hasConcept C2777683767 @default.
• W2141711493 hasConcept C2778527826 @default.
• W2141711493 hasConcept C2779134260 @default.
• W2141711493 hasConcept C2780558122 @default.
• W2141711493 hasConcept C2908647359 @default.
• W2141711493 hasConcept C29374701 @default.
• W2141711493 hasConcept C3017966228 @default.
• W2141711493 hasConcept C33923547 @default.
• W2141711493 hasConcept C44249647 @default.
• W2141711493 hasConcept C71924100 @default.
• W2141711493 hasConcept C89484641 @default.
• W2141711493 hasConcept C99454951 @default.
• W2141711493 hasConceptScore W2141711493C114614502 @default.
• W2141711493 hasConceptScore W2141711493C126322002 @default.
• W2141711493 hasConceptScore W2141711493C144024400 @default.
• W2141711493 hasConceptScore W2141711493C149923435 @default.
• W2141711493 hasConceptScore W2141711493C187212893 @default.
• W2141711493 hasConceptScore W2141711493C197947376 @default.
• W2141711493 hasConceptScore W2141711493C2777683767 @default.
• W2141711493 hasConceptScore W2141711493C2778527826 @default.
• W2141711493 hasConceptScore W2141711493C2779134260 @default.
• W2141711493 hasConceptScore W2141711493C2780558122 @default.
• W2141711493 hasConceptScore W2141711493C2908647359 @default.
• W2141711493 hasConceptScore W2141711493C29374701 @default.
• W2141711493 hasConceptScore W2141711493C3017966228 @default.
• W2141711493 hasConceptScore W2141711493C33923547 @default.
• W2141711493 hasConceptScore W2141711493C44249647 @default.
• W2141711493 hasConceptScore W2141711493C71924100 @default.
• W2141711493 hasConceptScore W2141711493C89484641 @default.
• W2141711493 hasConceptScore W2141711493C99454951 @default.
• W2141711493 hasIssue "6" @default.
• W2141711493 hasLocation W21417114931 @default.
• W2141711493 hasLocation W21417114932 @default.
• W2141711493 hasOpenAccess W2141711493 @default.
• W2141711493 hasPrimaryLocation W21417114931 @default.
• W2141711493 hasRelatedWork W100893883 @default.

• next